期刊文献+

血小板经不同活性基团mPEG修饰后功能变化的研究 被引量:1

Metergasis of platelets camouflaged by mPEG with different active groups
原文传递
导出
摘要 目的:观察血小板经不同mPEG修饰后功能变化情况,并分析其原因。方法:分别用mPEG-BTC、mPEG-SPA对血小板进行化学修饰;流式法检测修饰前后血小板CD62P荧光强度变化;并对血小板的聚集、黏附及释放功能进行检测。结果:经mPEG-BTC、mPEG-SPA修饰后,血小板CD62P表达率由修饰前的(12.77±2.87)%分别降至0和(4.12±1.28)%;聚集能力由修饰前的(1.43±0.74)%分别升至(3.86±1.21)%和(3.84±1.12)%;黏附能力由修饰前的(30.2±5.59)%分别升至(45.5±2.72)%和(45.2±3.99)%;而血小板Ca2+释放能力修饰前后差异无统计学意义。结论:使用mPEG-SPA对血小板进行化学修饰可影响血小板的功能,是一种较为理想的修饰剂。 Objective:To investigate the metergasis of platelets camouflaged by methoxy polyethylene glycols(mPEG) with different active groups, and to analyze its mechanism, nethods:Platelets were camouflaged by mPEG benzotriazole carbonate(mPEG-BTC) or succinimide of mPEG propionic acid(mPEG-SPA). The activated molecule CD62P of platelets was detected by flow cytometry and the platelet functions of aggregation, adhesiveness, and release were detected as well. Results:After the platelets were camouflaged by mPEG-BTC or mPEG-SPA, the expression rate of CD62P dropped from pre-modificatoin ( 12. 77 ± 2. 87) % to post-modification 0 and (4.12 ± 1.28 ) %, respectively. But the ability of aggrega- tion was enhanced from pre-modificatoin ( 1.43 ± 0. 74) % to post-modification ( 3.86 ±1.21 ) % and ( 3.84 ±1.12 ) %, and the ability of adhesion was enhanced from pre-modificatoin (30.2 ±5.59 )% to post-modification (45.5 ± 2.72 )% and (45.2 ±3.99 ) % respectively. The ability of Ca^2+ release was not influenced by the modification. Conclusion: The effect on the metergasis of platelets camouflaged by mPEG-SPA was less than that by mPEG-BTC, mPEG-SPA was a suitable modifier to camouflage platelets.
出处 《军事医学科学院院刊》 CSCD 北大核心 2007年第3期235-236,242,共3页 Bulletin of the Academy of Military Medical Sciences
关键词 血小板 甲氧基聚乙二醇 修饰 platelet mPEG camouflage
  • 相关文献

参考文献3

二级参考文献14

  • 1F奥斯伯 颜子颖译.精编分子生物学实验指南[M].北京:科学出版社,1998.671.
  • 2赵桐茂.HLA分析原理和应用[M].上海科学技术出版社,1984.279-80.
  • 3赵桐贸.人类血型遗传学[M].北京:科学出版社,1987.139.
  • 4Saito S, Ota M, Komatsu Y, et al. Serologic analysis of three cases of neonatal alloimmume thrombocytopenia associated with HLA antibodies [J]. Transfusion, 2003, 43 (7):908 - 917.
  • 5Juji T, Watanabe Y, Ishikawa Y, et al. Human platelet alloantigen (HPA)-5a/b mismatch decreases disease-free survival in unrelated bone marrow transplantation [ J]. Tissue Antigens, 1999, 54 (3): 229 - 234.
  • 6Glenn E. Rodey MD. HLA Beyond Tears: Introduction to human histocompatibility [ M]. 2nd ed. New York, USA: De NoVo Inc. Durango, CO, 2000: 67- 73.
  • 7Leach JK, Hinman A, O'Rear EA. Investigation of deformability, viscosity, and aggregation of mPEG-modified erythrocytes [J]. Biomed Sci Instrum, 2002, 38:333 - 338.
  • 8Scott MD, Chen AM. Beyond the red cell: pegylation of other blood cells and tissues [ J ]. Transfus Clin Biol, 2004,11 (1): 40-46.
  • 9Mozos E, Herraez P, Perez J, et al. Cutaneous lesions in experimental acute and subacute African swine fever: an immunohistopathological and ultrastructural study [ J]. Dtsch Tierarztl Wochenschr, 2003, 110 (4): 150- 154.
  • 10Bennet W, Sundberg B, Elgue G, et al. A new in vitro model for the study of pig-to-human vascular hyperacute rejection [J]. Xenotransplantation, 2001, 8 (3): 176- 184.

共引文献8

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部